(MedPage Today) — The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting treatments for generalized myasthenia gravis (gMG) in adults.
The phase IIIb study is designed to…
Source link : https://www.medpagetoday.com/meetingcoverage/aanemvideopearls/118558
Author :
Publish date : 2025-11-17 17:09:00
Copyright for syndicated content belongs to the linked Source.
